Mankind Pharma Q2 Results: Net Profit Rises 37.7% to ₹716 Crore, Revenue Grows 17.3%
Mankind Pharma Limited reported strong financial performance for the second quarter of FY27, with consolidated profit after tax (PAT) rising 37.7% year-on-year (YoY) to ₹716 crore. Revenue from operations increased 17.3% to ₹4,338 crore for the quarter ended September 30, 2026. The pharmaceutical company recorded growth across its domestic and international businesses, supported by demand […]
Mankind Pharma Q2 Results: Net Profit Rises 37.7% to ₹716 Crore, Revenue Grows 17.3% Read More »









